Immediate Impact
6 from Science/Nature 75 standout
Citing Papers
Oesophageal cancer
2024 Standout
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
Works of Eo-Jin Kim being referenced
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Eo-Jin Kim | 226 | 101 | 63 | 243 | 124 | 10 | 468 | |
| Satya M. Murthy | 139 | 67 | 58 | 220 | 142 | 12 | 508 | |
| J C Givel | 94 | 106 | 41 | 271 | 121 | 19 | 557 | |
| Edward W. Martin | 143 | 153 | 28 | 357 | 79 | 9 | 563 | |
| Elena García-García | 113 | 44 | 51 | 331 | 118 | 12 | 418 | |
| Pooja Patel | 188 | 40 | 50 | 220 | 117 | 13 | 461 | |
| Eugene A. Choi | 103 | 22 | 68 | 255 | 134 | 16 | 477 | |
| Irmgard Kronberger | 193 | 163 | 55 | 112 | 75 | 15 | 420 | |
| A. Spada | 177 | 56 | 83 | 227 | 93 | 17 | 418 | |
| Mikihiko Kimura | 283 | 45 | 17 | 277 | 105 | 13 | 561 | |
| Dario Fortunati | 144 | 29 | 17 | 153 | 198 | 17 | 535 |
All Works
Loading papers...